WNK2 activators represent a unique class of chemicals that interact with the WNK2 protein, a kinase implicated in various cellular processes. This chemical class is diverse, including a range of compounds that modulate the activity of WNK2, either directly or indirectly, through the manipulation of signaling pathways or cellular mechanisms in which WNK2 is a critical component. These activators are not uniform in their structure or mode of action but are unified by their ability to influence WNK2's activity within the cell. The direct activators bind to specific sites on the WNK2 protein, leading to conformational changes that can enhance the kinase's activity. This action may involve alteration in the phosphorylation state of WNK2 or its substrates, thereby modulating its signaling capabilities. These activators are of significant interest due to their role in modulating a kinase that is integral to various cellular functions, including ion transport and signal transduction.
Indirect activators, on the other hand, function through pathways or processes that converge on WNK2. These compounds can affect the upstream regulators or downstream targets of WNK2, thereby altering its activity. For example, some chemicals might enhance the expression of WNK2 or stabilize the protein, leading to increased activity. Others may interact with signaling pathways that are either upstream or downstream of WNK2, thus indirectly influencing its function. This indirect mode of activation adds a layer of complexity, as it involves a broader understanding of cellular networks and interactions. The study of WNK2 activators, both direct and indirect, provides valuable insights into the biological roles of WNK2 and the potential to modulate its activity in various cellular contexts. Their diversity in structure and mechanism reflects the complex nature of cellular signaling pathways and the intricate ways in which they can be modulated.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Spironolactone | 52-01-7 | sc-204294 | 50 mg | $109.00 | 3 | |
Aldosterone antagonist that can indirectly modulate WNK2 activity via the regulation of electrolyte balance and ion transport. | ||||||
Eplerenone | 107724-20-9 | sc-203943 sc-203943A | 10 mg 50 mg | $110.00 $624.00 | 4 | |
Selective aldosterone blocker, influencing WNK2 indirectly through aldosterone's effects on sodium and potassium homeostasis. | ||||||
Amiloride | 2609-46-3 | sc-337527 | 1 g | $296.00 | 7 | |
Sodium channel blocker that indirectly affects WNK2 by altering sodium transport, a process where WNK2 is implicated. | ||||||
Hydrochlorothiazide | 58-93-5 | sc-207738 sc-207738A sc-207738B sc-207738C sc-207738D | 5 g 25 g 50 g 100 g 250 g | $55.00 $240.00 $333.00 $562.00 $988.00 | ||
Diuretic that can indirectly affect WNK2 activity through its impact on electrolyte balance, particularly sodium and chloride. | ||||||
Angiotensin II, Human | 4474-91-3 | sc-363643 sc-363643A sc-363643B sc-363643C | 1 mg 5 mg 25 mg 100 mg | $51.00 $100.00 $310.00 $690.00 | 3 | |
As part of the renin-angiotensin system, it can indirectly modulate WNK2 through its effects on blood pressure and volume. | ||||||
Losartan | 114798-26-4 | sc-353662 | 100 mg | $130.00 | 18 | |
Angiotensin II receptor blocker, indirectly affecting WNK2 by modulating pathways involved in renal sodium and potassium handling. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Can indirectly modulate WNK2 activity by influencing cellular glucose uptake and metabolism, pathways where WNK2 is involved. | ||||||
Metformin-d6, Hydrochloride | 1185166-01-1 | sc-218701 sc-218701A sc-218701B | 1 mg 5 mg 10 mg | $292.00 $822.00 $1540.00 | 1 | |
Indirectly affects WNK2 by modulating metabolic pathways, particularly in glucose homeostasis, where WNK2 may play a role. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Activates adenylate cyclase, indirectly influencing WNK2 by elevating cAMP levels which can affect various signaling pathways. | ||||||